organization · Reporting owner
Morningside Venture Investments Ltd
Disclosed activity across 6 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apellis Pharmaceuticals, Inc.APLS · Entity 47322 | 10% owner | November 18, 2021 | November 18, 2021 |
| Apnimed, Inc.APMD · Entity 4910 | 10% owner | August 03, 2026 | August 05, 2026 |
| GreenLight Biosciences Holdings, PBCGRNA · Entity 111075 | 10% owner | July 24, 2023 | July 25, 2023 |
| Kezar Life Sciences, Inc.KZR · Entity 12111 | 10% owner | August 15, 2023 | August 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apellis Pharmaceuticals, Inc.
Report date November 18, 2021 · Filed November 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,806,342 |
Reported balance
After 2021-11-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-11-18 · Purchase · Acquired 250,000 · Balance 12,806,342 F1: Frances Anne Elizabeth Richard, Cheung Ka Ho, Jill Marie Franklin and Peter Stuart Allenby Edwards, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
Filing footnotes · ownership attribution and instrument terms
F1: Frances Anne Elizabeth Richard, Cheung Ka Ho, Jill Marie Franklin and Peter Stuart Allenby Edwards, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.
Apnimed, Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Last balance in matching sequence
After 2026-08-03 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-08-03 · Conversion · Acquired 6,840,213 · Balance 6,840,213 F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Row 2 · 2026-08-03 · Other · Disposed 6,840,213 · Balance 0 F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. |
| Common StockSEC Table I · non-derivative | Direct | 7,152,713 |
Last balance in matching sequence
After 2026-08-03 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2026-08-03 · Other · Acquired 6,840,213 · Balance 6,840,213 F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Row 4 · 2026-08-03 · Purchase · Acquired 312,500 · Balance 7,152,713 F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy MVIL, LLC | 0 |
Last balance in matching sequence
After 2026-08-03 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 5 · 2026-08-03 · Conversion · Acquired 75,624 · Balance 75,624 F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6: Represents securities held by MVIL, LLC. Row 6 · 2026-08-03 · Other · Disposed 75,624 · Balance 0 F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6: Represents securities held by MVIL, LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy MVIL, LLC | 75,624 |
Reported balance
After 2026-08-03 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2026-08-03 · Other · Acquired 75,624 · Balance 75,624 F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6: Represents securities held by MVIL, LLC. |
| Convertible Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-03 · Conversion · Disposed 9,227,454 · Balance 0 F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. |
| Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $14.40 | IndirectBy MVIL, LLC | 0 |
Reported balance
After 2026-08-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-03 · Conversion · Disposed 1,088,986.3 · Balance 0 F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F5: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6: Represents securities held by MVIL, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.
F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.
F3: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").
F4: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.
F5: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date.
F6: Represents securities held by MVIL, LLC.
GreenLight Biosciences Holdings, PBC
Report date July 24, 2023 · Filed July 25, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-07-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-07-24 · Other · Disposed 16,919,155 · Balance 0 F1: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary. F2: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary.
F2: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.
Kezar Life Sciences, Inc.
Report date August 15, 2023 · Filed August 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,947,993 |
Reported balance
After 2023-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-08-15 · Gift · Disposed 3,500,000 · Balance 1,947,993 F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.
F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Amylyx Pharmaceuticals, Inc.
Report date August 15, 2023 · Filed August 17, 2023
Section 16 reporting ended · disclosed 2023-08-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,997,302 |
Reported balance
After 2023-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-08-15 · Gift · Disposed 2,000,000 · Balance 4,997,302 F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares. F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares.
F2: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL.
Liquidia Technologies Inc
Report date July 30, 2018 · Filed August 01, 2018
Section 16 reporting ended · disclosed 2018-08-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 552,728 |
Last balance in matching sequence
After 2018-07-30 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2018-07-30 · Conversion · Acquired 442,819 · Balance 442,819 F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. Row 2 · 2018-07-30 · Conversion · Acquired 109,909 · Balance 552,728 F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
| Series C Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-07-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-30 · Conversion · Disposed 3,420,516 · Balance 0 F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
| Series D Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-07-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-07-30 · Conversion · Disposed 1,849,490 · Balance 0 F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
| Warrant to purchase Series D Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2026-12-31 | Direct | 0 |
Reported balance
After 2018-07-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-30 · Other · Disposed 319,664 · Balance 0 F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
| Warrant to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2026-12-31 | Direct | 18,996 |
Reported balance
After 2018-07-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-30 · Other · Acquired 18,996 · Balance 18,996 F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant. F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F2: The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F3: Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrants to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.
F4: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | ConversionConvertible Promissory Note · Derivative | 1,088,986.3 | $0.00 Strike: $14.40 | $0.00 |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · derivative · entry 9 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By MVIL, LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 75,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F4 · shares: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F4 · derivative.exercise_date: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F5 · derivative.expiration_date: The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date. F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6 · ownership.nature: Represents securities held by MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | ConversionConvertible Preferred Stock · Derivative | 9,227,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · derivative · entry 8 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,840,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | OtherCommon Stock | 75,624 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 7 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By MVIL, LLC Disclosed balance after: 75,624 F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6 · ownership.nature: Represents securities held by MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | OtherClass A Common Stock | 75,624 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 6 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By MVIL, LLC Disclosed balance after: 0 F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6 · ownership.nature: Represents securities held by MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | ConversionClass A Common Stock | 75,624 | $14.40 | $1,088,985.60 |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 5 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By MVIL, LLC Disclosed balance after: 75,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40. F2 · ownership.nature: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. F6 · ownership.nature: Represents securities held by MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | PurchaseCommon Stock | 312,500 | $16.00 | $5,000,000.00 |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 4 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,152,713 F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | OtherCommon Stock | 6,840,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 3 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,840,213 F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | OtherClass A Common Stock | 6,840,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · kind: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F3 · price: Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification"). F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:18 UTC | Apnimed, Inc. APMD · Entity 4910 | ConversionClass A Common Stock | 6,840,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-26-003483 · form4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,840,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 21:34 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | GiftCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-018211 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,997,302 F1 · shares: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:08 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | GiftCommon Stock | 3,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-043301 · ownership.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,947,993 F1 · shares: Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 20:01 UTC | GreenLight Biosciences Holdings, PBC GRNA · Entity 111075 | OtherCommon Stock | 16,919,155 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-034397 · ownership.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary. F2 · price: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent. F2 · ownership.direct: In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 29,048 | $30.45 | $884,511.60 |
DisclosureSEC source: 0000899243-23-010078 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,997,302 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $31.06, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 28, 2023 Filed Mar 29, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 100,000 | $30.37 | $3,037,000.00 |
DisclosureSEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 3 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,026,350 F3 · price: (The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.06 to $30.86, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 28,000 | $30.80 | $862,400.00 |
DisclosureSEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,126,350 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.74 to $30.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 32,964 | $30.25 | $997,161.00 |
DisclosureSEC source: 0000899243-23-009972 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,154,350 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $30.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 28,807 | $32.17 | $926,721.19 |
DisclosureSEC source: 0000899243-23-009506 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,187,314 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.005 to $32.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 34,641 | $31.69 | $1,097,773.29 |
DisclosureSEC source: 0000899243-23-009506 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,216,121 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:05 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 9,122 | $32.55 | $296,921.10 |
DisclosureSEC source: 0000899243-23-008858 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250,762 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.93, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:11 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 41,066 | $33.68 | $1,383,102.88 |
DisclosureSEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 3 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,259,884 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.505 to $34.460, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:11 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 108,934 | $33.12 | $3,607,894.08 |
DisclosureSEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300,950 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.5 to $33.5, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:11 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 70,714 | $34.54 | $2,442,461.56 |
DisclosureSEC source: 0000899243-23-008733 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,409,884 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $34.88, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 14:10 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 50,000 | $33.75 | $1,687,500.00 |
DisclosureSEC source: 0000899243-23-007120 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,480,598 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $34.04, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 21:13 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 1,111 | $36.24 | $40,262.64 |
DisclosureSEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 4 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,580,598 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 21:13 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 48,889 | $35.55 | $1,738,003.95 |
DisclosureSEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 3 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,581,709 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.14, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:13 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 10,084 | $36.34 | $366,452.56 |
DisclosureSEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,630,598 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.21 to $36.52, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:13 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 39,916 | $35.91 | $1,433,383.56 |
DisclosureSEC source: 0000899243-23-006123 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,640,682 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.20, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 22, 2023 Filed Feb 28, 2023 21:06 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 2,112 | $35.34 | $74,638.08 |
DisclosureSEC source: 0000899243-23-006394 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,530,598 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.45, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 22, 2023 Filed Feb 28, 2023 21:06 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | SaleCommon Stock | 47,888 | $34.70 | $1,661,713.60 |
DisclosureSEC source: 0000899243-23-006394 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,532,710 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.25, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:11 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 40,000 | $6.88 | $275,320.00 |
DisclosureSEC source: 0000899243-23-004187 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,447,993 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.82 to $7.08, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:11 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 25,000 | $7.15 | $178,650.00 |
DisclosureSEC source: 0000899243-23-004187 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,487,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.065 to $7.44, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:32 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 50,000 | $7.19 | $359,500.00 |
DisclosureSEC source: 0000899243-23-003869 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,512,993 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.32, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:32 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 40,000 | $6.95 | $278,000.00 |
DisclosureSEC source: 0000899243-23-003869 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,562,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.805 to $7.19, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 21:07 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 30,000 | $7.08 | $212,400.00 |
DisclosureSEC source: 0000899243-23-003120 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,602,993 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.92 to $7.18, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:07 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 30,000 | $6.91 | $207,300.00 |
DisclosureSEC source: 0000899243-23-003120 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,632,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.69 to $7.03, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:17 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 50,000 | $6.85 | $342,500.00 |
DisclosureSEC source: 0000899243-23-002854 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,662,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.77 to $6.96, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 24, 2023 Filed Jan 25, 2023 23:17 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 80,000 | $6.98 | $558,400.00 |
DisclosureSEC source: 0000899243-23-002677 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,712,993 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.095, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 23:17 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 80,000 | $6.81 | $544,800.00 |
DisclosureSEC source: 0000899243-23-002677 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,792,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $7.02, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:12 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 6,114 | $6.79 | $41,514.06 |
DisclosureSEC source: 0000899243-23-002157 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,872,993 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.84, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 21:28 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 1,971 | $7.15 | $14,092.65 |
DisclosureSEC source: 0000899243-23-001846 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879,107 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.37, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 21:28 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 5,000 | $6.77 | $33,850.00 |
DisclosureSEC source: 0000899243-23-001846 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,881,078 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.985 to $6.92, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:08 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 3,000 | $6.89 | $20,670.00 |
DisclosureSEC source: 0000899243-23-001293 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,886,078 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.68 to $7.12, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:08 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 12,162 | $6.97 | $84,769.14 |
DisclosureSEC source: 0000899243-23-001293 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,889,078 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.89 to $7.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 21:10 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 30,000 | $7.17 | $215,100.00 |
DisclosureSEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 3 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,901,240 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.91 to $7.28, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:10 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 500 | $7.10 | $3,550.00 |
DisclosureSEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,931,240 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.34, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| December 29, 2022 Filed Jan 5, 2023 21:10 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 25,000 | $7.10 | $177,500.00 |
DisclosureSEC source: 0000899243-23-000979 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,931,740 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.58 to $7.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| October 18, 2022 Filed Jan 11, 2023 21:09 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | GiftCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001583 · doc5.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,931,740 Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 20:05 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 3,612 | $8.82 | $31,857.48 |
DisclosureSEC source: 0000899243-22-032974 · doc4.xml · nonDerivative · entry 2 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,076,740 F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:05 UTC | Kezar Life Sciences, Inc. KZR · Entity 12111 | SaleCommon Stock | 28,700 | $8.78 | $251,957.30 |
DisclosureSEC source: 0000899243-22-032974 · doc4.xml · nonDerivative · entry 1 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,080,352 F1 · ownership.direct: Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL. Read SEC document |
| September 23, 2022 Filed Jan 11, 2023 21:07 UTC | Amylyx Pharmaceuticals, Inc. AMLX · Entity 259 | GiftCommon Stock | 833,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001580 · doc5.xml · nonDerivative · entry 4 Morningside Venture Investments Ltd · CIK 0001543112 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,680,598 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.